EyePoint (EYPT) Research & Development (2010 - 2026)

EyePoint has reported Research & Development for 17 years, with the latest figure at $72.1 million in Q1 2026.

• Quarterly Research & Development rose 206037.14% year-over-year to $72.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (down 92.89% YoY) and the FY2025 annual result came in at $90000.0, down 99.93% from the prior year.
• Research & Development grew to $72.1 million in Q1 2026 per EYPT's latest filing, from -$161.7 million in the prior quarter.
• Over five years, Research & Development peaked at $132.8 million in Q4 2024 and troughed at -$161.7 million in Q4 2025.
• A 5-year average of $16.5 million and a median of $15.7 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2026: Research & Development tumbled 692.09% in 2023, then surged 206037.14% in 2026.
• Over 5 years, Research & Development stood at $5.9 million in 2022, then sank by 692.09% to -$35.0 million in 2023, then surged by 479.32% to $132.8 million in 2024, then tumbled by 221.75% to -$161.7 million in 2025, then soared by 144.61% to $72.1 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $72.1 million, -$161.7 million, and $47.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.